<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Pfizer Inc. - Google Finance</title>
<description>News for Pfizer Inc. - Google Finance</description>
<link>http://www.google.com/finance?q=NYSE:PFE&amp;amp;client=news-rss&amp;amp;ei=cLabUYDVN8Ts0gHHWQ</link>
<image>
<title>News for Pfizer Inc. - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NYSE:PFE&amp;amp;client=news-rss&amp;amp;ei=cLabUYDVN8Ts0gHHWQ</link>
</image>
<item>
<title>Pfizer halts study of lymphoma drug unlikely to help survival</title>
<link>http://www.reuters.com/article/2013/05/20/us-pfizer-cancer-idUSBRE94J0VD20130520</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982067820311</guid>
<pubDate>Mon, 20 May 2013 22:01:12 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/article/2013/05/20/us-pfizer-cancer-idUSBRE94J0VD20130520&quot; style=&quot;font-size:1.2em&quot;&gt;Pfizer halts study of lymphoma drug unlikely to help survival&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;20 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;(Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it was not ...&lt;/div&gt;
&lt;a href=&quot;http://www.4-traders.com/PFIZER-INC-4821/news/Pfizer-Inc-Pfizer-Discontinues-Phase-3-Study-of-Inotuzumab-Ozogamicin-in-Relapsed-or-Refractory-A-16897330/&quot;&gt;PFIZER INC. : Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;4-traders (press release)&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.businessweek.com/ap/2013-05-20/pfizer-halts-study-of-non-hodgkins-lymphoma-drug&quot;&gt;Pfizer halts study of non-Hodgkin&amp;#39;s lymphoma drug&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Businessweek&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Pfizer Inc. (PFE)&amp;#39;s New Model</title>
<link>http://www.insidermonkey.com/blog/pfizer-inc-pfes-new-model-145959/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/pfizer-inc-pfes-new-model-145959/</guid>
<pubDate>Tue, 21 May 2013 14:28:06 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/pfizer-inc-pfes-new-model-145959/&quot; style=&quot;font-size:1.2em&quot;&gt;Pfizer Inc. (PFE)&amp;#39;s New Model&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;3 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;One of Pfizer Inc. (NYSE:PFE)&amp;#39;s best selling drugs is Viagra, which is used to treat erectile dysfunction. That particular ailment carries material social stigma and the pills, which are still under patent protection for many more years, can be ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Pfizer Inc. (PFE), Sanofi SA (ADR) (SNY), Onyx Pharmaceuticals, Inc. (ONXX ...</title>
<link>http://www.insidermonkey.com/blog/pfizer-inc-pfe-sanofi-sa-adr-sny-onyx-pharmaceuticals-inc-onxx-will-asco-unlock-big-value-in-this-cancer-drug-class-144745/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/pfizer-inc-pfe-sanofi-sa-adr-sny-onyx-pharmaceuticals-inc-onxx-will-asco-unlock-big-value-in-this-cancer-drug-class-144745/</guid>
<pubDate>Sun, 19 May 2013 16:39:16 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/pfizer-inc-pfe-sanofi-sa-adr-sny-onyx-pharmaceuticals-inc-onxx-will-asco-unlock-big-value-in-this-cancer-drug-class-144745/&quot; style=&quot;font-size:1.2em&quot;&gt;Pfizer Inc. (PFE), Sanofi SA (ADR) (SNY), Onyx Pharmaceuticals, Inc. (ONXX ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 19, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Pfizer Inc. (NYSE:PFE) is also getting in the action with its phase 1b trial of CVX-060 in combination Inlyta, with its FDA-approved drug.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Merck &amp;amp; Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) - Pick ...</title>
<link>http://www.insidermonkey.com/blog/merck-co-inc-mrk-pfizer-inc-pfe-astrazeneca-plc-adr-azn-pick-your-poison-overweight-or-high-cholesterol-144668/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982067550808</guid>
<pubDate>Mon, 20 May 2013 14:57:20 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/merck-co-inc-mrk-pfizer-inc-pfe-astrazeneca-plc-adr-azn-pick-your-poison-overweight-or-high-cholesterol-144668/&quot; style=&quot;font-size:1.2em&quot;&gt;Merck &amp;amp; Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) - Pick ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 20, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Merck &amp;amp; Co., Inc. (NYSE:MRK) Overweight and have high cholesterol? You may have to pick one to work on at a time, according to data from the lab of John Thyfault, an associate professor of nutrition and exercise physiology at University of Missouri.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Pfizer Inc. (PFE) and Merck &amp;amp; Co., Inc. (MRK) News: Expectations Of What&amp;#39;s ...</title>
<link>http://www.insidermonkey.com/blog/pfizer-inc-pfe-and-merck-co-inc-mrk-news-expectations-of-whats-next-gettin-bond-y-more-144517/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982064331624</guid>
<pubDate>Fri, 17 May 2013 19:30:41 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/pfizer-inc-pfe-and-merck-co-inc-mrk-news-expectations-of-whats-next-gettin-bond-y-more-144517/&quot; style=&quot;font-size:1.2em&quot;&gt;Pfizer Inc. (PFE) and Merck &amp;amp; Co., Inc. (MRK) News: Expectations Of What&amp;#39;s ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Editor&amp;#39;s Note: Pfizer Inc. (NYSE:PFE), Merck &amp;amp; Co., Inc. (NYSE:MRK), Petroleo Brasileiro Petrobras SA (NYSE:PBR), American Express Company (NYSE:AXP).&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Pfizer Inc. begins selling Viagra online to fight fake product sales</title>
<link>http://www.mlive.com/business/west-michigan/index.ssf/2013/05/pfizer_inc_selling_viagra_onli.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778147199067</guid>
<pubDate>Wed, 08 May 2013 16:43:51 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.mlive.com/business/west-michigan/index.ssf/2013/05/pfizer_inc_selling_viagra_onli.html&quot; style=&quot;font-size:1.2em&quot;&gt;Pfizer Inc. begins selling Viagra online to fight fake product sales&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;MLive.com&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 8, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;KALAMAZOO, MI - Pfizer Inc. is now delivering its erectile dysfunction Viagra tablets to patients who order it online to fight counterfeit product sales.&lt;/div&gt;
&lt;a href=&quot;http://www.smdailyjournal.com/articles/lifestyle/2013-05-07/bashful-buy-the-little-blue-pill-online/1767946.html&quot;&gt;Bashful? Buy the little blue pill online - San Mateo Daily Journal&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;San Mateo Daily Journal&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Buying Pfizer Inc. (PFE)&amp;#39;s History</title>
<link>http://www.insidermonkey.com/blog/buying-pfizer-inc-pfes-history-142331/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982062397788</guid>
<pubDate>Wed, 15 May 2013 18:25:36 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/buying-pfizer-inc-pfes-history-142331/&quot; style=&quot;font-size:1.2em&quot;&gt;Buying Pfizer Inc. (PFE)&amp;#39;s History&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;3 Drug Launches You Need to Know in 2013: Pfizer, NPS Pharma, Ariad Pfizer Inc. (NYSE:PFE) stock has been a boon for growth investors over the past year.&lt;/div&gt;
&lt;a href=&quot;http://utahpeoplespost.com/2013/05/pfizer-stock-rating-reaffirmed-by-thestreet-pfe/&quot;&gt;Pfizer Stock Rating Reaffirmed by TheStreet (PFE)&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;The Utah People&#39;s Post&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Ariad Pharmaceuticals, Inc. (ARIA), Pfizer Inc. (PFE), Celgene Corporation ...</title>
<link>http://www.insidermonkey.com/blog/ariad-pharmaceuticals-inc-aria-pfizer-inc-pfe-celgene-corporation-celg-whos-the-best-143532/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982063520269</guid>
<pubDate>Thu, 16 May 2013 19:00:24 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/ariad-pharmaceuticals-inc-aria-pfizer-inc-pfe-celgene-corporation-celg-whos-the-best-143532/&quot; style=&quot;font-size:1.2em&quot;&gt;Ariad Pharmaceuticals, Inc. (ARIA), Pfizer Inc. (PFE), Celgene Corporation ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Pfizer Inc. (NYSE:PFE) markets Oxecta, a narcotic pain medicine that uses the Aversion technology. However, the company can&amp;#39;t make claims of abuse deterrence because of FDA rules barring such language without extensive studies showing reduction in ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Apple Inc. (AAPL), General Electric Company (GE), Pfizer Inc. (PFE) &amp;amp; More ...</title>
<link>http://www.insidermonkey.com/blog/apple-inc-aapl-general-electric-company-ge-pfizer-inc-pfe-more-stalwarts-loved-by-advanced-investment-partners-143930/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/apple-inc-aapl-general-electric-company-ge-pfizer-inc-pfe-more-stalwarts-loved-by-advanced-investment-partners-143930/</guid>
<pubDate>Fri, 17 May 2013 13:54:18 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/apple-inc-aapl-general-electric-company-ge-pfizer-inc-pfe-more-stalwarts-loved-by-advanced-investment-partners-143930/&quot; style=&quot;font-size:1.2em&quot;&gt;Apple Inc. (AAPL), General Electric Company (GE), Pfizer Inc. (PFE) &amp;amp; More ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Advanced Investment Partners also holds shares of pharmaceutical giant Pfizer Inc. (NYSE:PFE), buying an additional 325,968 shares during the quarter, bringing the fund&amp;#39;s total holding to 566,138, as reported in the 13F.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Pfizer Inc. declares quarterly dividend; earnings report scheduled for April 30</title>
<link>http://www.mlive.com/business/west-michigan/index.ssf/2013/04/pfizer_inc_declares_quarterly.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778133602064</guid>
<pubDate>Fri, 26 Apr 2013 18:54:08 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.mlive.com/business/west-michigan/index.ssf/2013/04/pfizer_inc_declares_quarterly.html&quot; style=&quot;font-size:1.2em&quot;&gt;Pfizer Inc. declares quarterly dividend; earnings report scheduled for April 30&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Mlive Kalamazoo&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 26, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;KALAMAZOO, MI - Pfizer Inc.&amp;#39;s is declaring a $0.24 second-quarter dividend share to common stock shareholders. The dividend is payable on June 4, 2013, to shareholders of record at the close of business on May 10, 2013.&lt;/div&gt;
&lt;a href=&quot;http://www.theday.com/article/20130427/BIZ02/304279940/-1/BIZ&quot;&gt;Pfizer declares 24-cent dividend&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;TheDay.com (blog)&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
